|

PD-1 Inhibitor + Chemotherapy Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • West China Hospital1
  • Shenyang Sunshine Pharmaceutical Co., LTD.1

Indications

  • Cancer2
  • First-line Advanced NSCLC Patients1
  • TNBC - Triple-Negative Breast Cancer1
  • Lung Cancer1
  • Breast Cancer1

Other2 trials

A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients
Phase 2
SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.